Artificial Intelligence

Angebote

iCad

iCAD - ProFound AI for 2D and 3D Mammography

Highlights 

iCAD, with 20 years of experience, is the proven market leader in breast artificial intelligence. ProFound AI for 2D and 3D mammography detects and assesses malignant soft tissue densities and calcifications, and is extremely performant in subtle, hard to detect lesions such as those found in dense breasts. Proven clinical results show ProFound AI for DBT decreased radiologist reading time in half, while improving their breast cancer detection rates by 8 % and specificity rates by 7 %. iCAD’s breast health solutions suite also includes Density Assessment and ProFound AI Risk, the only two-year breast cancer risk tool based on a mammogram.

iCad

Suite 100 Nashua
03062 New Hampshire
USA

Verwandte Produkte

iCAD - Profound AI Risk

Artificial Intelligence

iCAD - Profound AI Risk

iCad
Newsletter abonnieren